Tag: epilepsy
NeuroPace announces early completion of patient enrolment in NAUTILUS pivotal study
NeuroPace has announced the completion of the patient enrolment goal in its NAUTILUS pivotal study for the treatment of idiopathic generalised epilepsy (IGE) “more...
LivaNova launches new vagus nerve stimulation therapy for drug-resistant epilepsy
LivaNova has launched SenTiva DUO—an implantable pulse generator (IPG) with a dual-pin header intended to provide vagus nerve stimulation (VNS) therapy for patients with...
NeuroPace initiates feasibility study of responsive neurostimulation for Lennox-Gastaut syndrome
NeuroPace has announced that the first patient with Lennox-Gastaut syndrome (LGS)—a particularly severe form of childhood-onset epilepsy characterised by cognitive dysfunction and frequent seizures—was...
Why responsive neurostimulation is garnering “wide interest” from the epilepsy field
To date, thalamic responsive neurostimulation (RNS) has shown real potential in the treatment of patients with drug-resistant epilepsy. Mark Richardson (Massachusetts General Hospital, Boston,...
NeuroPace announces first patient implant in NAUTILUS pivotal study
NeuroPace has announced the first patient has been implanted in the NAUTILUS clinical trial, a pivotal study that will evaluate the safety and effectiveness...
NeuroPace announces first treatment in pivotal study evaluating RNS system in...
NeuroPace has announced that the first patient was recently treated in the RESPONSE clinical trial, which is evaluating the safety and effectiveness of the...
Wyss Center, Inselspital Bern announce clinical trial of long-term brain monitoring...
As part of a recently announced clinical trial, brain signal recording with the Wyss Center for Bio and Neuroengineering’s novel brain-monitoring technology, its subscalp...
NeuroPace gains IDE approval to launch pivotal study of neuromodulation therapy...
NeuroPace has announced that it has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate the NAUTILUS...
UCB announces launch of Nile AI
UCB has announced the launch of Nile AI, a separate company, with the aim of developing an epilepsy care management platform. According to UCB,...
BioSerenity receives FDA clearance for EEG wearable device system
BioSerenity has announced that its electroencephalography (EEG) wearable device system has received 510(k) clearance from the US Food and Drug Administration (FDA). This clearance...
Physicians’ Education Resource releases agenda for the 1st Annual International Congress...
Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), announces the full agenda for the 1st Annual International Congress on...
NeuroPace present positive data from studies of the RNS System
NeuroPace has presented long-term clinical results demonstrating that the RNS System for refractory epilepsy significantly reduces seizure frequency in patients, with one in three...
Physicians’ Education Resource to host first annual International Congress on the...
Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), will host the first annual International Congress on the Future of...
Less-invasive procedure helps surgeons pinpoint epilepsy surgical candidates
A minimally invasive procedure to determine whether patients with drug-resistant epilepsy are candidates for brain surgery is safer, more efficient, and leads to better...
Positive results for the treatment of medication-resistant epilepsy using Neuroelectrics’ Starstim
At the recent American Epilepsy Society Annual Meeting in New Orleans, USA, Neuroelectrics presented positive results from its clinical trial treating patients with drug...
Medtronic’s deep brain stimulation for medically-refractory epilepsy launches in the USA
Medtronic has announced both the US launch of deep brain stimulation (DBS) for medically-refractory epilepsy and the first commercially implanted patient at Emory University...
NeuroPace announces new Category I CPT code for the RNS system
NeuroPace has announced that the American Medical Association (AMA) has issued a new Category I Current Procedural Terminology (CPT) code for electrocorticography from an implanted...
Medtronic receives FDA Approval for deep brain stimulation therapy for medically...
The US Food and Drug Administration (FDA) has granted premarket approval for Medtronic's deep brain stimulation (DBS) therapy as adjunctive treatment for reducing the...
NeuroPace closes US$74 million equity funding to accelerate commercialisation of epilepsy...
NeuroPace has closed a US$74 million round of funding led by the KCK Group and OrbiMed Advisors. This funding provides the resources necessary to...
FDA approves SenTiva device for treatment of epilepsy
LivaNova has received US Food and Drug Administration (FDA) approvals for its latest Vagus Nerve Stimulation (VNS) Therapy System, which consists of the SenTiva implantable...
LivaNova’s VNS Therapy receives CE mark for expanded MRI labelling
LivaNova's latest VNS Therapy system has received CE mark for expanded MRI labelling. VNS Therapy is now the only implantable device indicated for epilepsy...
LivaNova’s VNS Therapy receives FDA approval for expanded MRI labelling
LivaNova’s latest vagus nerve stimulation (VNS Therapy) system has received US Food and Drug Administration (FDA) approval for expanded magnetic resonance imaging labelling.
According...
ADDRESS trial of Prometra II infusion system begins
The first patients have been implanted with the Prometra II Programmable Infusion System in the ADDRESS (Australian direct drug administration for refractory epilepsy)clinical trial at...
AAN releases new guideline on how to map brain prior to...
Before epilepsy surgery, doctors may consider using brain imaging to locate language and memory functions in the brain instead of the more invasive procedure...
Flowonix Medical and Alliance Spine and Pain Centers announce first Prometra...
Flowonix Medical and Alliance Spine and Pain Centers have announced the first implant of the Prometra II intrathecal infusion pump in Georgia, USA. The...
